1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Research and Investment Value Analysis of China Chemical Pharmaceutical Industry, 2013-2017

Research and Investment Value Analysis of China Chemical Pharmaceutical Industry, 2013-2017

  • April 2013
  • -
  • Huidian Research
  • -
  • 101 pages

Summary

Table of Contents

Please note: The report is Chinese version. It will provide the English version in two business days

Chemical pharmaceutical is the main industry of China pharmaceutical market, occupying a pivotal position in the pharmaceutical industry. With the improvement of the national economical development and residents’ living standards, the chemical pharmaceutical market gradually expands and the position gradually improves in China. Seen from the industrial gross output value and growth rate, the proportion of industrial output value in GDP has kept increasing with a rapid growth since 2005. In the long run, because China chemical pharmaceutical industry is still in a relatively backward position, especially the R&D capacities of the original study medicine, in order to ensure medication needs of the broad masses of people and improve the international position of chemical pharmaceutical industry, it still gives strong support to the development of chemical pharmaceutical industry. On the other hand, the domestic demand for drugs still keeps increasing in China. With comprehensive consideration, the position of chemical pharmaceutical industry in the China national economy is expected to further enhance.

The chemical pharmaceutical industry has kept a high level and steady growth rate for recent 6 years, sales revenue of 2011 reaching CNY 715.516 billion and 23.40% growth rate, which is mainly influenced by the good economical development of China, rigid demand of an aging population, the introduction of a series of medical reform policy including increase in the proportion of health insurance reimbursement etc. In 2012, the sales revenue of chemical pharmaceutical was CNY 831.3 billion with 18.98% year-on –year growth.

In 2012, the chemical pharmaceutical industry still run high development trend basing on over 90% of production and marketing rate. It is predicted that this trend is hard to make immediate changes in short terms. It is predicted that the production capacity of the future chemical pharmaceutical industry will continuously enhance and the gross value of industrial output is expected to keep a higher growth. The production capacity of China pharmaceutical companies will also gradually enhance with the expansion of pharmaceutical market. Meanwhile, the chemical pharmaceutical industry face changes of development model and adjustments of industrial structure. For pharmaceutical companies, updating and restructuring is the only way to become bigger and stronger.

The implementation of the 12th- Five-Year plan of pharmaceutical industry points out the direction for the future development of chemical pharmaceutical industry. As the major industry of the emerging strategic development of the national economy in China, chemical pharmaceutical industry has more developing chances. Over the next 10 years, chemical pharmaceutical industry still face the development chances focusing on the drug price adjustment, structure adjustment, industry consolidation and restructuring and changes of development model. Supporting products, projects and enterprises which are in line with industry trends, will have good investment returns.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...

PharmaFocus: Tauopathies - Global Market Analysis

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...


ref:plp2013

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.